Biogena Group Invest AG (WBO:BIO) Shares Outstanding (EOP): 3.99 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:BIO Biogena Group Invest AG WBO:BIO
65 GF Score
Price €4.54
GF Value €3.47
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Biogena Group Invest AG Shares Outstanding (EOP)?

Biogena Group Invest AG WBO:BIO -1.73% 65 Shares Outstanding (EOP) is 3.99 Mil as of Jan. 2026. GuruFocus rates WBO:BIO with a GF Score™ of 65/100 and a GF Value™ of €3.47 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Biogena Group Invest AG's shares outstanding for the quarter that ended in Jan. 2026 was 3.99 Mil.

Biogena Group Invest AG's quarterly shares outstanding stayed the same from Jan. 2025 (3.99 Mil) to Jan. 2026 (3.99 Mil).

Biogena Group Invest AG's annual shares outstanding stayed the same from Jan. 2025 (3.99 Mil) to Jan. 2026 (3.99 Mil).


Biogena Group Invest AG  (WBO:BIO) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Biogena Group Invest AG Shares Outstanding (EOP) Related Terms


Biogena Group Invest AG Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Biogena Group Invest AG's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogena Group Invest AG Shares Outstanding (EOP) Chart

Biogena Group Invest AG Annual Data
Trend Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Shares Outstanding (EOP)
Get a 7-Day Free Trial 3.99 3.99 3.99 3.99 3.99

Biogena Group Invest AG Semi-Annual Data
Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Shares Outstanding (EOP) Get a 7-Day Free Trial 3.99 3.99 3.99 3.99 3.99

WBO:BIO vs KHC, GIS, HRL: Shares Outstanding (EOP) Comparison

For the Packaged Foods subindustry, Biogena Group Invest AG's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG Shares Outstanding (EOP) vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Shares Outstanding (EOP) falls into.


WBO:BIO
65GF Score
Biogena Group Invest AG WBO:BIO
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogena Group Invest AG Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 3.99 Mil mean?
Biogena Group Invest AG (WBO:BIO) has a Shares Outstanding (EOP) of 3.99 Mil as of Jan. 2026. The total shares a company has outstanding, at period-end. View historical data on Biogena Group Invest AG and its competitors.
Is Biogena Group Invest AG's Shares Outstanding (EOP) too high?
Biogena Group Invest AG's current Shares Outstanding (EOP) is 3.99 Mil. Overall, Biogena Group Invest AG has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's Shares Outstanding (EOP) compare to KHC and GIS?
Biogena Group Invest AG's Shares Outstanding (EOP) of 3.99 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Consumer Packaged Goods company?
A good Shares Outstanding (EOP) depends on the Consumer Packaged Goods industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Biogena Group Invest AG and its competitors. Biogena Group Invest AG's current Shares Outstanding (EOP) is 3.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.47, compared to a current price of €4.54 — trading 30.8% above its estimated fair value. The current Shares Outstanding (EOP) is 3.99 Mil. Biogena Group Invest AG's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current Shares Outstanding (EOP) is 3.99 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued. The current stock price of €4.54 is trading 30.8% above its estimated GF Value™ of €3.47. GuruFocus considers Biogena Group Invest AG to be Significantly Overvalued.

Key valuation signals for WBO:BIO:

  • Shares Outstanding (EOP): 3.99 Mil
  • GF Value™: €3.47 vs. price of €4.54 (30.8% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biogena Group Invest AG Business Description

Address Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
65GF Score

Get the complete analysis for WBO:BIO

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.54
Price
€3.47
GF Value